Rabbani-Chadegani Azra, Chamani Elham, Hajihassan Zahra
Department of Biochemistry, Institute of Biochemistry and Biophysics, University of Tehran, Tehran, Iran.
Eur J Pharmacol. 2009 Jun 24;613(1-3):34-8. doi: 10.1016/j.ejphar.2009.04.040. Epub 2009 Apr 24.
Vinorelbine (navelbin) belongs to vinca alkaloid anticancer drugs family with a broad spectrum of selective activity against mitotic microtubules. The present study is the first report demonstrating chromatin components as a novel target for vinorelbine in hepatocytes. The interaction was carried out in solution, employing fluorescence, UV spectroscopy and thermal denaturation techniques. Fluorescence emission spectra represented quenching of DNA chromospheres with drug and decreased fluorescence emission intensity in a dose-dependent manner. Binding of vinorelbine to chromatin induced very high hypochromicity and shifted DNA melting temperature to lower Tm. Vinorelbine binds to histone proteins with very high affinity when compared with the interaction of DNA intercalator anticancer drug, daunomycin, and the globular domain of the histones is considered as a main drug binding site. The results also showed that in the presence of vinorelbine, the absorbance of chromatin at 260 nm was decreased and the binding pattern was similar to daunomycin-chromatin complex. The results for the first time suggest that apart from tubulins, chromatin components can also be considered as a new target for this anticancer drug.
长春瑞滨(诺维本)属于长春花生物碱类抗癌药物家族,对有丝分裂微管具有广泛的选择性活性。本研究是首次报道证明染色质成分是长春瑞滨在肝细胞中的新靶点。相互作用在溶液中进行,采用荧光、紫外光谱和热变性技术。荧光发射光谱显示药物使DNA色球猝灭,并以剂量依赖方式降低荧光发射强度。长春瑞滨与染色质的结合诱导了非常高的减色效应,并将DNA解链温度移至较低的Tm值。与DNA嵌入剂抗癌药物柔红霉素的相互作用相比,长春瑞滨与组蛋白具有非常高的亲和力,并且组蛋白的球状结构域被认为是主要的药物结合位点。结果还表明,在长春瑞滨存在的情况下,染色质在260nm处的吸光度降低,并且结合模式与柔红霉素-染色质复合物相似。结果首次表明,除微管蛋白外,染色质成分也可被视为这种抗癌药物的新靶点。